NextCure, Inc. (NXTC)
NXTC moved a median of 0.00% 30 minutes after news, and -0.81% by the close. How NXTC actually reacts to news — the realized, point-in-time move the market made, measured across 200 labeled events over the last three years with zero look-ahead.
NXTC’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 32% | 177 |
| 30-min | 0.00% | 48% | 186 |
| 60-min | 0.00% | 47% | 198 |
| to close | -0.81% | 47% | 198 |
| Middle 50% of NXTC reactions | -2.35% to +2.37% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 200 |
Half of all NextCure, Inc. news events land between -2.35% and +2.37% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when NXTC moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to NXTC's baseline. Nothing else.
Recent NXTC events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form S-4/A NextCure, Inc. | SEC filing · Form S-4 | SEC EDGAR | +2.81% | -0.60% | |
| Form 8-K NextCure, Inc. For: Sep 21 | SEC filing · Form 8-K | SEC EDGAR | +2.99% | +1.20% | |
| Form 8-K NextCure, Inc. For: Sep 03 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.39% | |
| Form S-4 NextCure, Inc. | SEC filing · Form S-4 | SEC EDGAR | +3.72% | +0.89% | |
| Form 10-Q NextCure, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | -1.14% | +10.82% | |
| Form 8-K NextCure, Inc. For: Aug 06 | SEC filing · Form 8-K | SEC EDGAR | -1.14% | +10.82% | |
| NextCure Provides Business Update and Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | -1.14% | +10.82% | |
| Halper Sadeh LLC is Investigating Whether VEEE, NXTC, TCBK, FHB are Obtaining Fair Deals for their Shareholders | Press release | GlobeNewswire | +4.19% | -2.79% | |
| Form 8-K NextCure, Inc. For: Jul 14 | SEC filing · Form 8-K | SEC EDGAR | -7.65% | -28.63% | |
| NextCure and Avere Therapeutics Announce Merger to Advance Once-Weekly Oral IL-23 Therapy | Press release | GlobeNewswire | -7.65% | -28.63% | |
| NXTC Stock Alert: Halper Sadeh LLC is Investigating Whether NextCure, Inc. is Obtaining a Fair Price for its Shareholders | Press release | Business Wire | +2.64% | +2.17% | |
| Form 8-K NextCure, Inc. For: Jun 18 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -7.30% | |
| NXTC Announces Replay Available for Virtual KOL Event Discussing ASCO 2026 Dose Escalation Data from Phase 1 Trial of SIM0505 for Gynecologic Cancers | Press release | GlobeNewswire | -1.15% | +0.63% | |
| Form 8-K NextCure, Inc. For: Jun 01 | SEC filing · Form 8-K | SEC EDGAR | -3.74% | -51.44% | |
| NextCure Presents Positive SIM0505 Phase 1 Dose Escalation Data in Patients with Gynecologic Cancers at ASCO 2026 | Press release | GlobeNewswire | -3.74% | -51.44% | |
| Form 10-Q NextCure, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | -4.13% | |
| Form 8-K NextCure, Inc. For: May 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -4.13% | |
| NextCure Provides Business Update and Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +0.00% | -4.13% | |
| NextCure and Simcere Zaiming Initiate Dose Optimization for SIM0505 (CDH6 ADC) in Gynecologic Cancers | Press release | GlobeNewswire | +0.00% | -4.60% | |
| Form DEF 14A NextCure, Inc. For: Jun 18 | SEC filing · Form DEF | SEC EDGAR | -2.79% | -7.50% | |
| Form DEFA14A NextCure, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | -2.79% | -7.50% | |
| NextCure and Simcere’s SIM0505 (CDH6 ADC) Phase 1 Data to be Presented at ASCO 2026 | Press release | GlobeNewswire | +1.64% | -7.62% | |
| NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer | Press release | GlobeNewswire | +4.99% | +2.87% | |
| NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026 | Press release | GlobeNewswire | — | -3.92% | |
| Form 10-K NextCure, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | -2.75% | |
| Form 8-K NextCure, Inc. For: Mar 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -2.75% | |
| NextCure Provides Business Update and Reports Full Year 2025 Financial Results | Press release | GlobeNewswire | +0.00% | -2.75% | |
| Form 8-K NextCure, Inc. For: Jan 23 | SEC filing · Form 8-K | SEC EDGAR | -3.19% | -5.02% | |
| NextCure Provides Business Update | Press release | GlobeNewswire | -3.19% | -5.02% | |
| Form 8-K NextCure, Inc. For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | +1.22% | +0.43% | |
| Form EFFECT NextCure, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -2.45% | |
| Form D NextCure, Inc. | SEC filing · Form D | SEC EDGAR | -0.36% | +5.98% | |
| Form S-3 NextCure, Inc. | SEC filing · Form S-3 | SEC EDGAR | +2.49% | +3.07% | |
| NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference | Press release | GlobeNewswire | — | -3.76% | |
| Form 8-K NextCure, Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.35% | |
| NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts | Press release | GlobeNewswire | +0.00% | +0.35% | |
| NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules | Press release | GlobeNewswire | +4.71% | -2.72% | |
| Form 10-Q NextCure, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.52% | +2.61% | |
| Form 8-K NextCure, Inc. For: Nov 05 | SEC filing · Form 8-K | SEC EDGAR | -0.52% | +2.61% | |
| NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | -0.52% | +2.61% | |
| NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States | Press release | GlobeNewswire | +1.03% | +28.13% | |
| NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference | Press release | GlobeNewswire | — | +0.61% | |
| Form 8-K NextCure, Inc. For: Aug 21 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.75% | |
| Form 10-Q NextCure, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +3.77% | -0.81% | |
| Form 8-K NextCure, Inc. For: Aug 07 | SEC filing · Form 8-K | SEC EDGAR | +3.77% | -0.81% | |
| NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results | Press release | GlobeNewswire | +3.77% | -0.81% | |
| Form EFFECT NextCure, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -0.40% | -0.99% | |
| Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta | Press release | GlobeNewswire | -3.82% | +7.12% | |
| Form S-3 NextCure, Inc. | SEC filing · Form S-3 | SEC EDGAR | -1.60% | -0.20% | |
| Form 8-K NextCure, Inc. For: Jul 14 | SEC filing · Form 8-K | SEC EDGAR | +2.92% | +2.30% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the NXTC section they belong to.
Where else NXTC is measured.
NXTC earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is NextCure, Inc.'s median reaction calculated?
Every labeled NXTC news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 200 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of NXTC's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does NXTC's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.